- Home
- SRFM vs IPSC Comparison
SRFM vs IPSC Comparison
Compare SRFM & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SRFM
- IPSC
- Stock Information
- Founded
- SRFM 2011
- IPSC 2019
- Country
- SRFM United States
- IPSC United States
- Employees
- SRFM N/A
- IPSC N/A
- Industry
- SRFM Transportation Services
- IPSC Medicinal Chemicals and Botanical Products
- Sector
- SRFM Consumer Discretionary
- IPSC Health Care
- Exchange
- SRFM Nasdaq
- IPSC Nasdaq
- Market Cap
- SRFM 58.2M
- IPSC 58.1M
- IPO Year
- SRFM 2023
- IPSC 2021
- Fundamental
- Price
- SRFM $2.68
- IPSC $0.54
- Analyst Decision
- SRFM Strong Buy
- IPSC Strong Buy
- Analyst Count
- SRFM 3
- IPSC 5
- Target Price
- SRFM $6.02
- IPSC $3.67
- AVG Volume (30 Days)
- SRFM 95.8K
- IPSC 719.6K
- Earning Date
- SRFM 05-13-2025
- IPSC 05-20-2025
- Dividend Yield
- SRFM N/A
- IPSC N/A
- EPS Growth
- SRFM N/A
- IPSC N/A
- EPS
- SRFM N/A
- IPSC N/A
- Revenue
- SRFM $119,425,000.00
- IPSC $6,589,000.00
- Revenue This Year
- SRFM N/A
- IPSC $833.10
- Revenue Next Year
- SRFM $45.73
- IPSC N/A
- P/E Ratio
- SRFM N/A
- IPSC N/A
- Revenue Growth
- SRFM 97.38
- IPSC 194.81
- 52 Week Low
- SRFM $0.90
- IPSC $0.34
- 52 Week High
- SRFM $6.72
- IPSC $3.47
- Technical
- Relative Strength Index (RSI)
- SRFM 52.36
- IPSC 51.91
- Support Level
- SRFM $2.34
- IPSC $0.52
- Resistance Level
- SRFM $2.55
- IPSC $0.57
- Average True Range (ATR)
- SRFM 0.15
- IPSC 0.03
- MACD
- SRFM 0.06
- IPSC 0.00
- Stochastic Oscillator
- SRFM 82.35
- IPSC 58.75
About SRFM Surf Air Mobility Inc.
Surf Air Mobility Inc provides a regional air mobility platform to connect communities sustainably. The company is an electric aviation and air travel company expanding the category of regional air travel and reinventing flying through electrification. The company is building a regional air mobility ecosystem to sustainably connect the world's communities. It generates revenue through air mobility services.
About IPSC Century Therapeutics Inc.
Century Therapeutics Inc is a biotechnology company specializes in leveraging adult stem cells to develop advanced cell therapy products targeting cancer, autoimmune, and inflammatory diseases. Their innovative approach involves a genetically engineered allogeneic cell therapy platform comprising induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and cutting-edge manufacturing capabilities. This comprehensive platform aims to overcome the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and minimizing development and supply risks.